摘要
目的:探讨肌细胞增强因子2A基因P279L变异是否与冠心病相关。方法:选择西北地区汉族人385例,采用酚氯法提取全基因组DNA,应用聚合酶链式反应、限制性内切酶反应体系结合测序的方法检测MEF2A基因多态性。结果:冠心病组L、P等位基因的频率分别为16.53%和83.47%;对照组L、P等位基因的频率分别为5.48%和94.52%,MEF2A-P279L基因型在冠心病组和对照组的分布存在显著性的差异(P<0.01),而且L等位基因的分布频率在冠心病组显著高于对照组(P<0.01)。结论:MEF2A-P279L基因型在冠心病组和对照组的分布有显著性差异,与冠状动脉病变的严重程度显著相关,L等位基因的携带者冠心病发病率显著高于非携带者,而且冠脉的病变更为严重。
Objectives:To investigate the relationship between the distribution of Myocyte enhancer factor2A(MEF2A)gene P279 Lpolymorphism and CHD in Han nationality in Chinese North-Western area.Methods:Three hundred and eighty five Han ethnic subjects.DNA was extracted by proteinase K digestion,phenol and chloroform extraction as well as isopropanol precipitation.The polymerase chain reaction(PCR)-restriction fragment length polymorphisms(RFLP)in conjunction with sequencing were employed to test the single nucleotide polymorphisms(SNPs)in Myocyte enhancer factor 2A(MEF2A).Results:Lallelic frequency was significantly higher that in CHD group than that in control group,CHD group 16.53%,control group 5.48%(P〈0.01),Lallele was related with more severity of atherosclerosis in the coronary artery than P allele(P〈0.01).Conclusion:There is significantly statistical difference of distribution frequency and severity of atherosclerosis in the coronary artery of three genotypes of MEF2A-P279 Lpolymorphism in CHD and control group,but also L allele is related with more morbility of CHD and severity of atherosclerosis in the coronary artery.
出处
《陕西医学杂志》
CAS
2015年第2期162-163,共2页
Shaanxi Medical Journal
基金
西安市科技计划基金项目(2011HM1115)